 | Up a level |
2022
Nunes, Carolina 
ORCID: 0000-0002-8564-6171, Depestel, Lisa ORCID: 0000-0001-5690-3258, Mus, Liselot, Keller, Kaylee M. ORCID: 0000-0002-3130-7465, Delhaye, Louis ORCID: 0000-0001-8876-7385, Louwagie, Amber ORCID: 0000-0003-1808-6749, Rishfi, Muhammad ORCID: 0000-0002-6386-4485, Whale, Alex, Kara, Neesha, Andrews, Simon R., Dela Cruz, Filemon, You, Daoqi, Siddiquee, Armaan, Cologna, Camila Takeno, De Craemer, Sam, Dolman, Emmy, Bartenhagen, Christoph, De Vloed, Fanny, Sanders, Ellen, Eggermont, Aline, Bekaert, Sarah-Lee ORCID: 0000-0002-4769-3460, Van Loocke, Wouter, Bek, Jan Willem ORCID: 0000-0003-1337-1970, Dewyn, Givani, Loontiens, Siebe ORCID: 0000-0002-4602-4580, Van Isterdael, Gert ORCID: 0000-0001-6626-1316, Decaesteker, Bieke, Tilleman, Laurentijn ORCID: 0000-0001-7584-1179, Van Nieuwerburgh, Filip ORCID: 0000-0001-8815-5485, Vermeirssen, Vanessa, Van Neste, Christophe, Ghesquiere, Bart ORCID: 0000-0003-1547-1705, Goossens, Steven, Eyckerman, Sven, De Preter, Katleen, Fischer, Matthias, Houseley, Jon, Molenaar, Jan, De Wilde, Bram ORCID: 0000-0003-0213-1322, Roberts, Stephen S., Durinck, Kaat ORCID: 0000-0003-1762-5739 and Speleman, Frank
(2022).
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition.
Sci. Adv., 8 (28).
WASHINGTON:
AMER ASSOC ADVANCEMENT SCIENCE.
ISSN 2375-2548
2020
Moreno, Lucas, Barone, Giuseppe, DuBois, Steven G., Molenaar, Jan, Fischer, Matthias, Schulte, Johannes, Eggert, Angelika ORCID: 0000-0003-3476-8184, Schleiermacher, Gudrun, Speleman, Frank, Chesler, Louis, Geoerger, Birgit, Hogarty, Michael D., Irwin, Meredith S., Bird, Nick, Blanchard, Guy B., Buckland, Sean, Caron, Hubert, Davis, Susan, De Wilde, Bram, DeubZer, Hedwig E., Dolman, Emmy, Eilers, Martin, George, Rani E., George, Sally, Sterba, Jaroslav, Maris, John M., Marshall, Lynley, Merchant, Melinda, Mortimer, Peter, Owens, Cormac, Philpott, Anna, Poon, Evon, Shay, Jerry W., Tonelli, Roberto, Valteau-Couanet, Dominique, Vassal, Gilles, Park, Julie R. and Pearson, Andrew D. J.
(2020).
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma.
Eur. J. Cancer, 136.
S. 52 - 69.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1879-0852
2017
Moreno, Lucas ORCID: 0000-0002-0708-1670, Caron, Hubert, Geoerger, Birgit, Eggert, Angelika, Schleiermacher, Gudrun, Brock, Penelope, Valteau-Couanet, Dominique, Chesler, Louis ORCID: 0000-0001-7842-2068, Schulte, Johannes H., De Preter, Katleen, Molenaar, Jan, Schramm, Alexander ORCID: 0000-0001-7670-7529, Eilers, Martin, Van Maerken, Tom, Johnsen, John Inge, Garrett, Michelle, George, Sally L., Tweddle, Deborah A., Kogner, Per ORCID: 0000-0002-2202-9694, Berthold, Frank, Koster, Jan ORCID: 0000-0002-0890-7585, Barone, Giuseppe, Tucker, Elizabeth R., Marshall, Lynley, Herold, Ralf ORCID: 0000-0002-8148-6748, Sterba, Jaroslav, Norga, Koen, Vassal, Gilles and Pearson, Andrew D. J.
(2017).
Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project.
Expert. Opin. Drug Discov., 12 (8).
S. 801 - 812.
ABINGDON:
TAYLOR & FRANCIS LTD.
ISSN 1746-045X